Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.

Genes - 29 Dec 2020

Ghidini Michele, Lampis Andrea, Mirchev Milko B, Okuducu Ali Fuat, Ratti Margherita, Valeri Nicola, Hahne Jens C

Abstract excerpt

Pancreatic cancer is one of the most aggressive malignancies with limited treatment options thus resulting in high morbidity and mortality. Among all cancers, with a five-year survival rates of only 2-9%, pancreatic cancer holds the worst prognostic outcome for patients. To improve the overall survival, an earlier diagnosis and stratification of cancer patients for personalized treatment options are urgent needs....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Colorectal Neoplasms, Hereditary Nonpolyposis

Share to Immune Checkpoint Inhibitors

Share to Microsatellite Instability

Share to Pancreatectomy

Share to Patient Selection

Source

Open in PubMed Open full text

Identifiers

PMID: 33383713
DOI: 10.3390/genes12010033
PMCID: PMC7823781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.PMID 33383713Read ↗

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancersSemantic proximity Read ↗

Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies.Semantic proximity Read ↗

New therapeutic targets in pancreatic cancer.Semantic proximity Read ↗

Advances and prospects of biomarkers for immune checkpoint inhibitorsSemantic proximity Read ↗

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacySemantic proximity Read ↗

Emerging Treatment Strategies in Pancreatic Cancer.Semantic proximity Read ↗

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read ↗

Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repairSemantic proximity Read ↗

Immunotherapy and patients treated for cancer with microsatellite instability.Semantic proximity Read ↗

Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging TherapiesSemantic proximity Read ↗

Identification of Genetic Determinants of Pancreatic Cancer Immune Phenotypes by Integrative Genome-scale AnalysisSemantic proximity Read ↗

The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.